Pulmonary Embolism News and Research

RSS

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.

Exploring adverse outcomes in post-COVID-19 condition patients

In a recent study published in the JAMA Health Forum, researchers assessed the adverse outcomes observed among post-coronavirus disease 2019 (COVID-19) condition (PCC) patients as compared to non-COVID-19 (NC) persons.

7 Mar 2023

Youth overweight increases risk for blood clots later in life

Being overweight in childhood and in early adulthood are discrete risk factors for blood clots later in life, a University of Gothenburg study shows.

2 Mar 2023

Hormone replacement therapy for gender dysphoria may increase risk of serious cardiac events

People with gender dysphoria taking hormone replacements as part of gender affirmation therapy face a substantially increased risk of serious cardiac events, including stroke, heart attack and pulmonary embolism, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

23 Feb 2023

Using genetic risk scores for predicting venous thromboembolism

Researchers assess the predictability of venous thromboembolism among adults using genetic risk scores.

5 Feb 2023

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

Researchers evaluated adverse events in older adults after mRNA vaccination for COVID-19.

24 Jan 2023

More high-risk patients with pulmonary embolism may benefit from surgical intervention

A new American Heart Association scientific statement suggests surgery be considered for more people with high-risk pulmonary embolism (PE).

23 Jan 2023

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis.

4 Jan 2023

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Researchers compared coronavirus disease 2019 (COVID-19)-specific long-term consequences to other viral respiratory infections.

29 Dec 2022

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Researchers observe that COVID-19 patients were at an increased risk of developing certain conditions.

21 Dec 2022

Study reports that delaying surgery post-COVID-19 reduces the risk of postoperative cardiovascular issues

Researchers assessed the temporal relationship between COVID-19 diagnosis and surgery time with the risk of occurrence of cardiovascular morbidity events within 30 days of surgery.

16 Dec 2022

Surgical risk for patients who’ve had COVID persists longer than previously known

When patients undergo any type of surgery after having had COVID, their odds of significant postoperative problems diminish with elapsed time from COVID diagnosis.

15 Dec 2022

No benefit of low dose apixaban following acute COVID-19

The HEAL-COVID trial compared the efficacy of Apixaban to standard care in adults who have recently recovered from severe COVID-19.

14 Dec 2022

Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications

Researchers determine the rates of thrombosis, thrombocytopenia, and thrombosis with thrombocytopenia following COVID-19 vaccination and infection.

28 Nov 2022

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today.

24 Nov 2022

U.S. COVID-19 vaccine safety surveillance results for the over 65s

In a recent study posted to the medRxiv* server, researchers conducted near real-time safety monitoring in the United States (US) elderly population for 14 safety outcomes weekly following the coronavirus disease 2019 (COVID-19) vaccination

7 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

Pulmonary Embolism News and Research

Further Reading

Exploring adverse outcomes in post-COVID-19 condition patients

Youth overweight increases risk for blood clots later in life

Hormone replacement therapy for gender dysphoria may increase risk of serious cardiac events

Using genetic risk scores for predicting venous thromboembolism

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

More high-risk patients with pulmonary embolism may benefit from surgical intervention

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

What are the long-term consequences following COVID-19 and other viral respiratory infections?

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Study reports that delaying surgery post-COVID-19 reduces the risk of postoperative cardiovascular issues

Surgical risk for patients who’ve had COVID persists longer than previously known

No benefit of low dose apixaban following acute COVID-19

Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

U.S. COVID-19 vaccine safety surveillance results for the over 65s

Paxlovid antiviral therapy reduces risk of long COVID

Evaluating dual direct-acting antivirals against persistent COVID-19

Study suggests anti-PF4 antibodies may play a role in the severe multiorgan disease manifestations of COVID-19

Does maternal obesity impact fetal brain development?

Study sheds new light on the risk of rare blood-clotting condition after covid-19 vaccination

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News